Autonomix Medical (NASDAQ:AMIX) Trading 1.7% Higher – Still a Buy?

Autonomix Medical, Inc. (NASDAQ:AMIX)’s share price traded up 1.7% during mid-day trading on Wednesday . The stock traded as high as $0.62 and last traded at $0.61. 114,673 shares were traded during mid-day trading, a decline of 57% from the average session volume of 264,849 shares. The stock had previously closed at $0.5999.

Analysts Set New Price Targets

AMIX has been the subject of several research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Autonomix Medical in a research note on Wednesday, October 8th. Zacks Research downgraded Autonomix Medical from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 28th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $5.00.

Autonomix Medical Trading Up 1.7%

The company’s 50-day moving average is $0.90 and its 200 day moving average is $1.13. The firm has a market cap of $4.22 million, a PE ratio of -0.13 and a beta of -2.87.

Autonomix Medical (NASDAQ:AMIX) last posted its quarterly earnings data on Wednesday, November 12th. The company reported ($1.38) earnings per share for the quarter, hitting the consensus estimate of ($1.38). On average, research analysts predict that Autonomix Medical, Inc. will post -10 EPS for the current fiscal year.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.